Dynamics Special Purpose Corp. (DYNS) to Combine with Senti Biosciences

Dynamics (NASDAQ:DYNS) has entered into a definitive agreement to combine with leading Gene Circuit company Senti Biosciences at an enterprise value of $276 million. San Francisco-based Senti Bio uses its Gene Circuit platform to develop next-generation cell and gene therapies to enhance therapeutic effectiveness against diseases. The combined company is expected to be listed on
Read More